PRDX3 and benign prostatic hyperplasia: Emerging evidence implicates OS (e.g., Prdx3 dysregulation), autophagy impairment, and pyroptosis in BPH pathogenesis, though their interactions with canonical drivers (e.g., androgen signaling, NF-κB activation) require further elucidation.